Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer.

Although there was a decreasing trend observed in mitotic and vessel counts of the GSNO treated mice tumors, we could not detect a significant change ( Fig. 5F–G ).

also in 47,180 other papers